SEC Form 4 · accession 0001127602-19-008759
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Benkowitz
Officer — President and COO
Period of report
Feb 27, 2019
Accepted (ET)
Feb 27, 2019 · 5:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 1,480 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2,F3 | $111.00 | Feb 27, 2019 | A | 64,148 | A | Mar 15, 2019 | Mar 15, 2028 | Common Stock | 64,148 | 64,148 | D |
Explanation of responses
- F1Includes 188 shares acquired on March 2, 2018 under the United Therapeutics Corporation Employee Stock Purchase Plan ("ESPP").
- F2These performance-based stock options were initially awarded on March 15, 2018, subject to a one-year performance condition tied to company-wide milestone performance for 2018, which was determined on February 27, 2019. Number of stock options reported represents the number of options earned based on milestone performance.
- F3These stock options vest in one-third increments on each of March 15, 2019, 2020 and 2021.